SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-043670
Filing Date
2019-11-18
Accepted
2019-11-18 07:33:35
Documents
71
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q freq-10q_20190930.htm 10-Q 2774198
2 EX-31.1 freq-ex311_206.htm EX-31.1 17980
3 EX-31.2 freq-ex312_207.htm EX-31.2 18019
4 EX-32.1 freq-ex321_205.htm EX-32.1 9552
5 EX-32.2 freq-ex322_204.htm EX-32.2 9582
  Complete submission text file 0001564590-19-043670.txt   7398801

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT freq-20190930.xml EX-101.INS 1252542
7 XBRL TAXONOMY EXTENSION SCHEMA freq-20190930.xsd EX-101.SCH 48539
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE freq-20190930_cal.xml EX-101.CAL 39771
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE freq-20190930_def.xml EX-101.DEF 207119
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE freq-20190930_lab.xml EX-101.LAB 389905
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE freq-20190930_pre.xml EX-101.PRE 324634
Mailing Address 19 PRESIDENTIAL WAY, SUITE 203 WOBURN MA 01801
Business Address 19 PRESIDENTIAL WAY, SUITE 203 WOBURN MA 01801 781-315-4600
Frequency Therapeutics, Inc. (Filer) CIK: 0001703647 (see all company filings)

IRS No.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39062 | Film No.: 191226160
SIC: 2834 Pharmaceutical Preparations